Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -1.82%.However, over the last six months, we can see a stronger performance of -25.49%. Over the last 30 days, the price of IPA has fallen by 3.16%. And in the last five days, it has surged by 7.36%.
ImmunoPrecise Antibodies Ltd experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $1.48 on 04/08/24, while the lowest price for the same period was registered at $0.27 on 03/04/25.
52-week price history of IPA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. ImmunoPrecise Antibodies Ltd’s current trading price is -72.69% away from its 52-week high, while its distance from the 52-week low is 49.70%. The stock’s price range during this period has varied between$0.27 and $1.48. The ImmunoPrecise Antibodies Ltd’s shares, which operate in the Healthcare, saw a trading volume of around 0.7 million for the day, a figure considerably lower than their average daily volume of 7.57 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
ImmunoPrecise Antibodies Ltd (IPA) has experienced a quarterly decline of -22.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 18.50M and boasts a workforce of 101 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4308, with a change in price of -0.0358. Similarly, ImmunoPrecise Antibodies Ltd recorded 4,836,672 in trading volume during the last 100 days, posting a change of -8.14%.
IPA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for IPA stands at 0.51. Similarly, the long-term debt-to-equity ratio is also 0.45.
IPA Stock Stochastic Average
ImmunoPrecise Antibodies Ltd’s raw stochastic average for the past 50 days is presently 34.41%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 59.61%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 35.14% and 31.42%, respectively.
